247 related articles for article (PubMed ID: 9294848)
41. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus.
Stenqvist AC; Nagaeva O; Baranov V; Mincheva-Nilsson L
J Immunol; 2013 Dec; 191(11):5515-23. PubMed ID: 24184557
[TBL] [Abstract][Full Text] [Related]
42. Human lung carcinomas express Fas ligand.
Niehans GA; Brunner T; Frizelle SP; Liston JC; Salerno CT; Knapp DJ; Green DR; Kratzke RA
Cancer Res; 1997 Mar; 57(6):1007-12. PubMed ID: 9067260
[TBL] [Abstract][Full Text] [Related]
43. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack.
Maher S; Toomey D; Condron C; Bouchier-Hayes D
Immunol Cell Biol; 2002 Apr; 80(2):131-7. PubMed ID: 11940113
[TBL] [Abstract][Full Text] [Related]
44. [Study on the expression of Fas ligand on the surfaces of human cytotrophoblasts in normal pregnancy].
Qiu H; Sun Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Jul; 36(7):402-4. PubMed ID: 11718024
[TBL] [Abstract][Full Text] [Related]
45. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
46. Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis.
Koji T; Hishikawa Y; Ando H; Nakanishi Y; Kobayashi N
Biol Reprod; 2001 Mar; 64(3):946-54. PubMed ID: 11207212
[TBL] [Abstract][Full Text] [Related]
47. Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis.
Payne SG; Smith SC; Davidge ST; Baker PN; Guilbert LJ
Biol Reprod; 1999 May; 60(5):1144-50. PubMed ID: 10208976
[TBL] [Abstract][Full Text] [Related]
48. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
49. Expression of Fas-Fas ligand in murine testis.
Xu JP; Li X; Mori E; Guo MW; Matsuda I; Takaichi H; Amano T; Mori T
Am J Reprod Immunol; 1999 Dec; 42(6):381-8. PubMed ID: 10622469
[TBL] [Abstract][Full Text] [Related]
50. The expression of Fas/FasL and apoptosis in yak placentomes.
JiangFeng F; Jiu YS; Wen ZZ; Ben L
Anim Reprod Sci; 2011 Oct; 128(1-4):107-16. PubMed ID: 22014664
[TBL] [Abstract][Full Text] [Related]
51. RT in situ PCR for the detection of mRNA transcripts of Fas-L in the immune-privileged placental environment.
Steele A; Uckan D; Steele P; Chamizo W; Washington K; Koutsonikolis A; Good RA
Cell Vis; 1998; 5(1):13-9. PubMed ID: 9660719
[TBL] [Abstract][Full Text] [Related]
52. Immune privilege or inflammation? The paradoxical effects of Fas ligand.
O'Connell J
Arch Immunol Ther Exp (Warsz); 2000; 48(2):73-9. PubMed ID: 10807046
[TBL] [Abstract][Full Text] [Related]
53. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
[TBL] [Abstract][Full Text] [Related]
54. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
[TBL] [Abstract][Full Text] [Related]
55. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege.
Ohshima K; Nakashima M; Sonoda K; Kikuchi M; Watanabe T
Clin Exp Immunol; 2001 Mar; 123(3):481-6. PubMed ID: 11298137
[TBL] [Abstract][Full Text] [Related]
56. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
[TBL] [Abstract][Full Text] [Related]
57. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
[TBL] [Abstract][Full Text] [Related]
58. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival.
Runic R; Lockwood CJ; Ma Y; Dipasquale B; Guller S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3119-22. PubMed ID: 8768884
[TBL] [Abstract][Full Text] [Related]
59. Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen.
Mor G; Kohen F; Garcia-Velasco J; Nilsen J; Brown W; Song J; Naftolin F
J Steroid Biochem Mol Biol; 2000; 73(5):185-94. PubMed ID: 11070347
[TBL] [Abstract][Full Text] [Related]
60. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta.
Huppertz B; Frank HG; Kingdom JC; Reister F; Kaufmann P
Histochem Cell Biol; 1998 Nov; 110(5):495-508. PubMed ID: 9826129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
